2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
Open Access
- 1 October 2016
- journal article
- practice guideline
- Published by Elsevier BV in Atherosclerosis
- Vol. 253, 281-344
- https://doi.org/10.1016/j.atherosclerosis.2016.08.018
Abstract
No abstract availableKeywords
This publication has 100 references indexed in Scilit:
- Effects of a Fixed-Dose Combination Strategy on Adherence and Risk Factors in Patients With or at High Risk of CVDJAMA, 2013
- Role of Colesevelam in Combination Lipid-Lowering TherapyAmerican Journal of Cardiovascular Drugs, 2013
- Monitoring of Lipids, Enzymes, and Creatine Kinase in Patients on Lipid-Lowering Drug TherapyCurrent Cardiology Reports, 2013
- Effects of Combination Lipid Therapy on Coronary Stenosis Progression and Clinical Cardiovascular Events in Coronary Disease Patients With Metabolic Syndrome: A Combined Analysis of the Familial Atherosclerosis Treatment Study (FATS), the HDL-Atherosclerosis Treatment Study (HATS), and the Armed Forces Regression Study (AFREGS)The American Journal of Cardiology, 2009
- Major Lipids, Apolipoproteins, and Risk of Vascular DiseaseJAMA, 2009
- Effect of Xuezhikang, an Extract From Red Yeast Chinese Rice, on Coronary Events in a Chinese Population With Previous Myocardial InfarctionThe American Journal of Cardiology, 2008
- Fasting Compared With Nonfasting Triglycerides and Risk of Cardiovascular Events in WomenJAMA, 2007
- Nonfasting Triglycerides and Risk of Myocardial Infarction, Ischemic Heart Disease, and Death in Men and WomenJAMA, 2007
- Statins, High-Density Lipoprotein Cholesterol, and Regression of Coronary AtherosclerosisJAMA, 2007
- The theory of planned behaviorOrganizational Behavior and Human Decision Processes, 1991